Influenza antivirals are divided into the following two categories of direct-acting drugs: neuraminidase (NA) inhibitors (NAIs) that target the NA enzyme to prevent virus budding and the cap-dependent endonuclease inhibitor, baloxavir marboxil. Here, XK is linked to influenza.